- Home
- FLYE vs GCTK Comparison
FLYE vs GCTK Comparison
Compare FLYE & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLYE | GCTK |
|---|---|---|
| Founded | 2018 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 2.5M |
| IPO Year | 2024 | 2011 |
Fundamental Metrics
Financial Performance| Metric | FLYE | GCTK |
|---|---|---|
| Price | $1.66 | $0.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.5K | ★ 18.2M |
| Earning Date | 04-21-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.82 | N/A |
| EPS | N/A | ★ 2.65 |
| Revenue | ★ $19,063,357.00 | $589,462.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.14 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.48 | $0.25 |
| 52 Week High | $21.80 | $14.14 |
Technical Indicators
Market Signals| Indicator | FLYE | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 45.02 | 47.83 |
| Support Level | $1.66 | $0.28 |
| Resistance Level | $2.30 | $0.68 |
| Average True Range (ATR) | 0.13 | 0.13 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 35.29 | 22.02 |
Price Performance
Historical ComparisonAbout FLYE Fly-E Group Inc.
Fly-E Group Inc is principally engaged in designing, installing, and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories under the Fly E-Bike brand. The Company encourages the adoption of eco-friendly transportation for active lifestyles.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.